Benjamin Musher
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- Viral gastroenteritis research and epidemiology
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Neutropenia and Cancer Infections
Papers in
- Co-authors
- Wendy M. Leisenring (2 shared papers)Kieren A. Marr (2 shared papers)S. Arunmozhi Balajee (2 shared papers)Daniel M. Musher (4 shared papers)Michael Boeckh (1 shared paper)W. Garrett Nichols (1 shared paper)Lawrence Corey (1 shared paper)Fulvio Crippa (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Blood (2 papers)Journal of Surgical Research (2 papers)Clinical Epigenetics (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)
- Partner nations
- United StatesSwedenAustralia
In The Last Decade
Benjamin Musher
36 papers receiving 999 citations
Benjamin Musher's Hit Papers
Peers
Comparison fields: 5 of 79
- Infectious Diseases 535
- Oncology 324
- Epidemiology 387
- Small Animals 54
- Biotechnology 35
Countries citing papers authored by Benjamin Musher
This map shows the geographic impact of Benjamin Musher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Musher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Musher more than expected).
Fields of papers citing papers by Benjamin Musher
This network shows the impact of papers produced by Benjamin Musher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Musher. The network helps show where Benjamin Musher may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Musher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 310 | |
| 2 | 2004 | 196 | |
| 3 | 2004 | 110 | |
| 4 | 2015 | 85 | |
| 5 | LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study Hit paper breakdown → | 2024 | 45 |
| 6 | 2017 | 34 | |
| 7 | 2016 | 28 | |
| 8 | 2005 | 25 | |
| 9 | 2020 | 25 | |
| 10 | 2014 | 24 | |
| 11 | 2022 | 17 | |
| 12 | 2019 | 16 | |
| 13 | 2022 | 11 | |
| 14 | 2020 | 11 | |
| 15 | 2018 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2023 | 10 | |
| 18 | 2018 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2020 | 6 |
About Benjamin Musher
Benjamin Musher is a scholar working on Oncology, Surgery, Epidemiology, Genetics and Biotechnology, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), CAR-T cell therapy research (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Research and Treatments (4 papers), Virus-based gene therapy research (4 papers), Colorectal Cancer Surgical Treatments (3 papers), Antifungal resistance and susceptibility (2 papers) and Fungal Infections and Studies (2 papers). The work is most often cited by research in Infectious Diseases (535 citations), Oncology (324 citations), Epidemiology (387 citations), Small Animals (54 citations) and Biotechnology (35 citations). Benjamin Musher has collaborated with scholars based in United States, Sweden and Australia. Frequent co-authors include Wendy M. Leisenring, Kieren A. Marr, S. Arunmozhi Balajee, Daniel M. Musher, Michael Boeckh, W. Garrett Nichols, Lawrence Corey, Fulvio Crippa, Caitlin A. Smith and David N. Fredricks. Their work appears in journals such as Journal of Clinical Oncology, Blood, Journal of Surgical Research, Clinical Epigenetics and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.